Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT04078217 |
Other study ID # |
CER VN 18-19-38 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
September 3, 2019 |
Est. completion date |
June 2021 |
Study information
Verified date |
November 2020 |
Source |
Université du Québec a Montréal |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The study will aim to determine whether a technology-based personalized home exercise program
delivered asynchronously and supervised remotely by a kinesiologist is more effective in
improving gait than a similar home-based exercise program without technology nor remote
supervision. The main hypothesis is that the proposed intervention with the technology will
provide significant improvements in gait performance and higher adherence/satisfaction over
the non-supervised exercise program.
Both groups will be composed of people with Parkinson's disease. They will have the same
evaluation pre and post intervention, the same number of visits from the kinesiologist to
deliver the exercise program at home. The difference is the information gathered from the
technology; for example, the completion level of each training, success or failure of
selected exercises, connection to exercise session, etc. In addition, kinesiologist can
remotely adjust difficulty of exercise and take action quickly if the participant hasn't
logged in the training system.
Total duration for a participant is 16 weeks: pre-evaluation at home and at lab, 12 weeks
home-based exercise program, post-evaluation at home and lab (same as before exercise
program).
Pre- and post-evaluation: 7 days wearing an Apple watch to measure mobility in participant
environment (participant is met at home and continues normal activities), than comes to lab
to undergo physical and balance tests, and scans to analyse body composition (fat, muscle and
bone structures). Participant needs to be in "off" state when arriving at the lab; not have
taken the morning PD medication. Will take it at the lab with breakfast, after the first
tests.
Description:
The specific aims of this project are: a) to determine whether a technology-based
personalized home exercise program delivered asynchronously and supervised remotely by a
kinesiologist is more effective in improving gait than a traditional home-based exercise
program, b) to assess the system acceptability and satisfaction, c) to examine and compare
the impact of both approaches on several secondary outcome measures related to mobility, PD
symptom, and quality of life. This study is a prospective randomized controlled
single-blinded clinical trial of efficacy of a technology asynchronous assisted supervised
tele-exercise program compared to an a traditional home-based exercise program with a
booklet.
Interventions:
Control group (CONT): The participants (n=21) included in control group will follow a
non-supervised home-based exercise program (booklet format). The exercise program will
include 3 physical activity sessions per week for 12 consecutive weeks. This exercise regimen
has been shown to be adequate to improve functional capacities in elderly and feasible. Each
exercise session will last 40-45 minutes and includes: 1) 5 minutes of warm-up exercises; 2)
15-18 minutes of mobility and balance exercises (e.g. high knees, lateral launches, side
steps); 3) 15-18 minutes of strengthening and coordination exercises (e.g. weight transfer
and squats, leg extension and balance, lateral shifting, horizontal flexion and extension)
and; 4) 5 minutes for cool down/stretching. This exercise protocol was developed based on
general guidelines for the prescription of exercises to older adults and, validated in a
previous study. The exercise booklet will be introduced and supervised for the first sessions
by a trained kinesiologist. Follow-ups by phone will happen at sessions 6, 12 and 18. During
these follow-up calls, if the answers are "yes" to the 3 following questions (1. Did the
participant perform during the last weeks all the exercise sessions? 2. Did the participant
feel safe when performing exercises? 3. Did the participant find easier to perform the
exercises compared to the last contact?), then the participant will be invited, but not
obligated, to increase the level of difficulty using the option indicated in the booklet.
JIN Group (n=21): The JIN group (n=21) will receive an individualized asynchronous supervised
home-base exercise program using the Jintronix System, 3 times/week for 12 weeks (36
sessions). This exercise regimen has shown to be adequate to improve functional capacities in
elderly. Briefly, the Jintronix Rehabilitation System (JRS) uses Microsoft Kinect cameras to
track patient's movements in 3D during exercises. They are programmed as games that are
visualized on a television and for which performance feedback is provided to the participant.
Developed by Jintronix system designers in partnership with researchers, the system provides
an interactive exergame environment to execute, specialized exercises through specific
instructions and real-time feedback. The Jintronix system which includes a computer, the
software and a motion capture device will be installed at participants' homes on their own
television. A trained kinesiologist will install the system and supervise the exercise
program. Participants will be trained to use the system with help of the kinesiologist during
the visits. Each exercise session will last 40-45 minutes and includes: 1) 5 minutes of
warm-up exercises; 2) 15-18 minutes of mobility and balance exercises (e.g. high knees,
lateral launches, side steps); 3) 15-18 minutes of strengthening and coordination exercises
(e.g. weight transfer and squats, leg extension and balance, lateral shifting, horizontal
flexion and extension) and; 4) 5 minutes for cool down/stretching. Based on the Web-portal
daily reports on the performance of the exercise program, the kinesiologist will do online
adjustment of the degree of difficulty of the individualized exercises by increasing the
number of repetitions, number of series, intensity and range of motion and provide feedback
to the participant. This will ensure individualized adaptations and progress throughout the
12-week intervention.
The JIN group will use the Jintronix rehabilitation software to exercise at home whereas the
CONT group will use an exercise booklet. Both groups will be free to exercise on the 3 days
and times that best suit their schedule, with a mandatory minimum of one day off between
sessions. In addition, to counteract human interaction bias, both exercise groups will have
the same number and type of contact. The first weeks following the baseline evaluation, 3 to
4 in-person home visits are required to ensure proper and safe execution of exercise protocol
(both groups) and the capacity to use the technology (JIN group only). In addition to these
visits, 3 follow-up phone calls will be given to allow the kinesiologist to ensure safety and
adherence. An emergency contact number will be given to participants for any questions
regarding the exercise regimen during the 12-week intervention.
Study workflow and monitoring: After a phone screening to ensure eligibility and obtaining an
oral consent to participate, participants will follow 2 baseline visits: 1 at their home and
1 at the "Université du Québec à Montréal" (UQAM). Before the home visit, subjects will be
randomized into control (CONT) or Jintronix® (JIN). During the first visit at home,
participants will sign an informed consent form. Afterward, the visit will be divided in 2
parts. The first part will serve to complete validated questionnaires (Parkinson's Disease
Questionnaire, Short Falls Efficacy Scale-International and Life Space Assessment). The
second part is to install the wearable equipment for mobility assessment (Apple watch® and
location beacons). Participants will wear the sensor for at least 7 consecutive days.
Afterwards, participants will return wearable sensors and location beacons at the UQAM visit.
They will arrive in the morning in "off" state (abstinence of medication 12h before
appointment) to undergo the motor evaluation, which is the 6-minute walk test, and the Short
Physical Performance Battery test. After these, participants will take their medication with
a breakfast at the lab. While waiting to be "on" state, investigators will perform the body
composition (DEXA) and muscle composition scans (Ct-scan). When the medication is fully in
effect, functional capacity and 6-min walk tests will be re-assessed. This will provide us
comparison measures. All evaluations will be repeated at the end of the exercise intervention
using the same sequence.
Power analysis:
Sample size: Primary outcome measure is the average gait speed assessed during a 6-minute
walk test. Based on previous studies, obtaining clinically significant improvement in gait
speed needs to show a gain of 0.2m/sec after intervention. Data using the proposed technology
yielded significant improvement (JIN:+0,2±0,12m/s vs CONT:0,05 ±0,09m/s; p=0.025). Thus,
obtaining a power of 0.80, an alpha of 0.05, with an effect size of 0.5 (which is
significantly smaller that the investigators previously obtained (1.37)), this project would
need a total sample size of 28 participants (14 per group) to detect clinically significant
differences in gait speed changes between two groups. However, considering an attrition rate
of 20% (3 out of 14 in each group) and to improve chances to achieve adequate power for
secondary outcomes, a sample of 21 participants per group (n=42) will be used. Even if
adequate power is not achieved for the secondary outcomes' measures, sample sizes between 24
and 50 are sufficient to calculate the standard deviation of outcome measures gathered during
a feasibility study, to estimate the sample size required for hypothesis testing in a
randomized control trial (RCT). Thus, calculations will ensure a sufficient power analysis
for the primary outcome measure and position the investigators to establish the variability
on secondary measures for a larger RCT.
Statistical analyses: Descriptive statistics (means, standard deviations, ranges, normality,
and proportions) will be determined for all study variables. The primary outcome, gait speed,
will be assessed using a two-way mixed model analysis of variance (ANOVA) where group is the
between factor and time is the within factor. Tukey post hoc or Friedman test will be used
based on data characteristics. Categorical variables related to the outcome measures (i.e.
clinical scales and diary) will be analyzed using χ2 or Fisher exact tests for baseline
comparisons. The change in each outcome variable (before and after training) will be modeled
in an unadjusted 1-factor (group) analysis of variance, to investigate the effect of
interventions. Wearable sensor data will be averaged over multiple days and compared using a
two-way mixed model ANOVA as described above, similar to other secondary outcome measures
(i.e. DEXA, CT-Scan, etc.). Tukey post hoc or Friedman test will be used based on data
characteristics. To examine changes in variability, standard deviations will be averaged over
multiple days and compared using the same approach. Finally, exploratory analyses will be
performed to examine 1) if the JIN intervention allows to improve on/off periods, 2) the
possible effect of age, sex or medication dose on exercise adaptations.
Innovation: Patients with PD are likely to experience a decrease in their daily physical
activity (PA) because of physical impairments, fatigue, and apathy. PA is a complement to
pharmacological interventions to manage the inherent decline in function associated with the
disease. It is well known that PA interventions induce positive effects on physical
capacities and more specifically on gait, mobility, posture and balance. However, engaging
older adults in PA through different modalities of exercise programs to obtain these benefits
is a challenge, as more than half of older adults are inactive physically and patients with
PD are even more than older adults. Supervised exercise programs are needed to motivate and
engage patients with PD in becoming more physically active in structured and safe ways.
Providing access to supervised exercise programs for patients is difficult as they have
mobility constrains and they rely on others for their travel. Home Exercise Programs (HEPs)
offer potential benefits but are often lacking close supervision and interaction with a
healthcare professional. The use of a supervised in-home PA program driven and supported by
an exergame such as Jintronix© has the potential to be more impactful and meaningful to
patients than traditional HEPs. It can be used independently by them in their own home and do
not require the presence of a professional to perform physical activity training. This allows
patients to perform exercise as they wish (schedule, day, on/off period etc.) which overall
will increase their adherence to the PA program and promote self-engagement and
self-management of their PD. The technology provides a unique way to engage patients in PA
while ensuring supervision and communication with a health care professional. The proposed
works will also innovate by using an ecological mobility measurement approach based on
wearable sensors to capture gait and activity metrics under real life conditions for
multiples days and link this to medication use. The combination of sensors used (inertial
sensor at the ankle, and interior and exterior location sensors) and their packaging into
highly usable and wearable form factors is highly innovative and unique. The proposed
instrumentation for the measurement approach offers a lot of potential to study the impacts
of pharmacological and non-pharmacological interventions on real life functions and
activities of patients. It could be of interest to other parties involved in clinical trials
on interventions for PD.